The effects of variants of some RAAS constituents genes, including angiotensin-converting enzyme (ACE), as well as angiotensinogen and angiotensin II type 1 receptor (AT1R), on the risk of DN, were extensively studied (8, 9). This evidence concerns the gene AGTR1 and liver dysplastic nodule.